Neurology devices Market by Product (Neurostimulation Devices, Neurosurgery Device, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, and Others) and End User (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics): Global Opportunity Analysis and Industry Forecast, 2019–2026
The global neurological devices market was valued at $9,242.67 million in 2018, and is expected to reach $ 17,410.40 million by 2026, registering a CAGR of 8.1% from 2019 to 2026. Neurovascular devices such as cerebrospinal fluid management devices and interventional devices majorly find their application in the treatment of neurological disorders, including Alzheimer’s, tumors, depression, and stroke. Moreover, there are various other devices or instruments used for the treatment of neurological diseases such as catheters, stents, ultrasonic aspirators, and stereotactic system.
The growth of the global neurology devices market is driven by significant rise in geriatric population across the globe, rise in demand for minimally invasive surgeries, and development of advanced neurological devices. In addition, increase in prevalence of neurological disorders across the globe propels the demand for neurology devices, thereby supplementing the growth of the global market. In addition, rise in geriatric population poses risk for increase in incidence of neurovascular disorders (such as stroke). However, enforcement of stringent government regulations toward the approval of these devices and lack of skilled neurosurgeons are the key factors anticipated to hamper the market growth. Conversely, the introduction of new products and technological advancements in neurological devices have aided in the efficient treatment of many neurovascular disorders, which is expected to provide lucrative opportunities for market expansion during the forecast period.
The global neurological devices market is segmented into product, end user, and region. By product, the market is categorized into neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Depending on end user, it is classified into hospitals, neurology clinics, and ambulatory care centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS - The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets. - It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities. - Comprehensive analysis of four regions is provided to determine the prevailing opportunities. - Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
By End User • Hospitals • Neurology Clinics • Ambulatory Care Centers
By Region • North America o U.S. o Canada o Mexico • Europe o Germany o France o UK o Italy o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Rest of Asia-Pacific • LAMEA o Brazil o Saudi Arabia o South Africa o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT • Abbott Laboratories • B. Braun Melsungen AG • Boston Scientific Corporation • Integra LifeSciences Holdings Corporation • LivaNova PLC • Johnson & Johnson • Medtronic Plc • Magstim Co Ltd. • Penumbra, Inc. • Stryker Corporation
Our reports have been used by over 10K customers, including:
Carpal Tunnel Syndrome Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2020" provides an overview of Carpal Tunnel Syndrome Clinical trials scenario.This report provides top line data relating to the clinical...
188 pages •
By Global Industry Analysts
• Sep 2020
Global Surgical Drainage Devices Market to Reach $3.6 Billion by 2027 Amid the COVID-19 crisis, the global market for Surgical Drainage Devices estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027. Orthopedics, one of...
Central Nervous Systems Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Central Nervous Systems Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Central...
The Neurovascular Devices market was valued at US$ 2,997.36 million in 2019 and is projected to reach US$ 3,871.20 million by 2027; it is expected to grow at a CAGR of 3.2% from 2020 to 2027. The market is driven by the factors such as,increasing incidences of neurovascular diseases, rising demand for minimally invasive procedures,...
The Vascular Embolization Market is expected to register a CAGR of 5.8% during the forecast period. Vascular embolization is a procedure, in which an embolic agent is injected into the blood vessel to close them and stop the blood flow to a targeted area. Embolization procedure is advantageous compare to other procedures due to minimally invasive...
200 pages •
By The Business Research Company
• Sep 2020
Major players in the interventional neurology devices and equipment market are Medtronic, Stryker, TERUMO CORPORATION, Penumbra and Covidien. The global interventional neurology devices and equipment market is expected to decline from $2.3 billion in 2019 to $1.9 billion in 2020 at a compound annual growth rate (CAGR) of -17.6%. The...
Neurovascular Neurology Devices Market Research Report by Type (Carotid Artery Stenting System, Cerebral Aneurysm and AVM Endovascular Embolization Systems, Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, and Intracranial Stent Systems), by Application (Cerebral Aneurysm, Cerebral Artery Stenosis, and Stroke) - Global Forecast...
183 pages •
By Global Industry Analysts
• Sep 2020
Global Neurovascular Devices/Interventional Neurology Market to Reach $3.5 Billion by 2027 Amid the COVID-19 crisis, the global market for Neurovascular Devices/Interventional Neurology estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 7.3% over the analysis...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.